Business
fromwww.theguardian.com
4 days agoPharma shake-up: Surprise change of CEO at GSK, as AstraZeneca announces New York stock market listing business live
GSK appoints Luke Miels as CEO Designate to succeed Emma Walmsley, effective 1 January 2026, after nine years and a company overhaul.